Dynamic Alterations of Th2/Th1 With New Onset of Community-acquired Severe Sepsis Patients

NCT02883218 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 85

Last updated 2018-08-21

No results posted yet for this study

Summary

To evaluate the dynamic alterations of Th2/Th1 for the prediction of clinical immunity and how it was related to 28 day-prognosis and ICU-acquired infections among critically ill patients of community-acquired severe sepsis with new onset.

Conditions

Sponsors & Collaborators

  • Jianfeng Xie

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2018-07-20
Completion
2018-08-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02883218 on ClinicalTrials.gov